# Kyverna Therapeutics, Inc.: Form 8-K, filed Jun 3, 2025

- Company: [Kyverna Therapeutics, Inc.](/companies/kytx.md) (CIK 1994702)
- Form: 8-K
- Filed: 2025-06-03
- Accepted by EDGAR: Jun 3, 2025, 20:03 ET
- Period: 2025-05-29
- Accession: 0000950170-25-080896
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1994702/000095017025080896/kytx-20250529.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1994702/000095017025080896/

## Items reported

- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1994702/000095017025080896/kytx-20250529.htm

Filed Jun 3, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-080896. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.